Global biological sample collections from tuberculosis studies: a scoping review
The Lancet Microbe · 2026
DOI: 10.1016/j.lanmic.2025.101287 ↗Kurz gefasst
Scoping Review in der Zeitschrift The Lancet Microbe, 2026. Verfasst von Cara Adolph und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for International Health, University of Otago, Dunedin, New Zealand. Electronic address: cara.adolph@otago.ac.nz. Hauptthemen laut MEDLINE: Tuberculosis, Specimen Handling, Biological Specimen Banks. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gates Foundation, National Institutes of Health, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Progress in tuberculosis vaccine development is hindered by the incomplete understanding of protective immunity and other disease mechanisms. An interconnected network of sample biorepositories from tuberculosis studies could help to address these gaps. To assess the feasibility of such a resource, we conducted a scoping review of tuberculosis observational studies and vaccine clinical trials. The included studies collected at least one biological sample from tuberculosis cases, contacts, or controls and had more than 100 participants. We contacted the corresponding authors of these studies to determine the sample availability and interest in interconnected biorepositories. For the period 2014-24, we identified 104 observational studies and 18 vaccine trials that collected biological samples from 35 075 tuberculosis cases, 39 450 contacts or controls, and 45 628 trial participants across 43 countries. The commonly collected samples were blood, human genomic DNA, RNA, and sputum. Interest among the contacted investigators was high. Interconnected sample biorepositories could facilitate large-scale investigations and accelerate progress towards tuberculosis vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for International Health, University of Otago, Dunedin, New Zealand. Electronic address: cara.adolph@otago.ac.nz.
- South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
- Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, and Tuberculosis Imaging Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), Nation…
- Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
- Centre for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA; Centre for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health and Science University, Portland, OR, USA.
Förderung
- Gates Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Division of Intramural Research
Zitieren
APA
Adolph, C., Mendelsohn, S. C., Via, L. E., Martinez, L., Lindestam Arlehamn, C. S., Lewinsohn, D. M., Torrelles, J. B., & Hill, P. C. (2026). Global biological sample collections from tuberculosis studies: a scoping review. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101287
Vancouver
Adolph C, Mendelsohn SC, Via LE, Martinez L, Lindestam Arlehamn CS, Lewinsohn DM, et al. Global biological sample collections from tuberculosis studies: a scoping review. The Lancet Microbe. 2026. doi:10.1016/j.lanmic.2025.101287
BibTeX
@article{Adolph2026,
author = {Adolph, Cara and Mendelsohn, Simon C and Via, Laura E and Martinez, Leonardo and Lindestam Arlehamn, Cecilia S and Lewinsohn, David M and Torrelles, Jordi B and Hill, Philip C},
title = {Global biological sample collections from tuberculosis studies: a scoping review},
journal = {The Lancet Microbe},
year = {2026},
doi = {10.1016/j.lanmic.2025.101287}
}
EUVIMED